Valeant trims drug portfolio by selling iNova to Carlyle and Pacific Equity
Bourne Partners, Midatech and Cathaway Capital also made deals for pharmaceutical companies.
Use phrases "in quotes" or the tools below to better filter your results.
This is premium content
To read the full story, please upgrade your plan to Gold, Platinum, or Enterprise.
Upgrade plan